e-Drug3D 1300 |
ATAZANAVIR
|
cas 198904-31-3 |
CLASS ANTIINFECTIVES |
ROUTE (list) ORAL |
PK parameters Tmax 2.5 HOUR Solubility SLIGHTLY SOLUBLE IN WATER 4 TO 5 MILLIGRAM / MILLILITER WITH THE PH=1.9 AT 24 DEGREE CELSIUS |
Target TARGET HIV-1 PROTEASE PDB Ligand code = DR7 (link to the list of PDB complexes) Download experimental 3D coordinates of DR7 with added hydrogens |
DrugCentral Pol polyprotein UNIPROT Q72874 pol |
Download SDF file | methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate Formula: Calculated chemical properties: MW 704.86 NB_atoms 51 XLogP 4.21 PSA 147.131 NB_HD 5 NB_HA 13 fsp3 0.45 Lipinski(0=no;1=yes) 0 |
FDA NDA 021567 (pdf not found) INN (ATAZANAVIR SULFATE) REYATAZ (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 2003 NDA 078785 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (EMCURE PHARMA) APPROVAL= TA YEAR= 2008 NDA 091611 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (MATRIX LABS LTD) APPROVAL= TA YEAR= 2010 NDA 200196 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (EMCURE PHARMS) APPROVAL= TA YEAR= 2010 NDA 022282 (pdf not found) INN (ATAZANAVIR SULFATE ; RITONAVIR) ATAZANAVIR SULFATE AND RITONAVIR (MATRIX LABS LTD) APPROVAL= TA YEAR= 2011 NDA 091673 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2014 NDA 205508 (pdf not found) INN (ATAZANAVIR SULFATE ; RITONAVIR) ATAZANAVIR SULFATE; RITONAVIR (EMCURE PHARMS LTD) APPROVAL= TA YEAR= 2014 NDA 206041 (pdf not found) INN (ATAZANAVIR SULFATE ; RITONAVIR ; LAMIVUDINE ; ZIDOVUDINE) ATAZANAVIR SULFATE;RITONAVIR;LAMIVUDINE;ZIDOVUDINE (MYLAN LABS LTD) APPROVAL= TA YEAR= 2014 NDA 206352 (pdf not found) INN (ATAZANAVIR SULFATE) REYATAZ (BRISTOL MYERS SQUIBB) APPROVAL= AP YEAR= 2014 NDA 206353 (pdf not found) INN (ATAZANAVIR SULFATE ; COBICISTAT) EVOTAZ (BRISTOL) APPROVAL= AP YEAR= 2015 NDA 091641 (pdf not found) INN (ATAZANAVIR) ATAZANAVIR (PHARMACARE LTD) APPROVAL= TA YEAR= 2017 OBSOLETE NDA 204806 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (AUROBINDO PHARMA) APPROVAL= AP YEAR= 2018 NDA 200626 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (CIPLA) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 208177 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (MYLAN) APPROVAL= AP YEAR= 2018 DISCONTINUED NDA 209717 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (AMNEAL) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 210575 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (ZYDUS PHARMS) APPROVAL= AP YEAR= 2020 DISCONTINUED NDA 212579 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (LAURUS) APPROVAL= AP YEAR= 2021 NDA 212278 (pdf not found) INN (ATAZANAVIR SULFATE) ATAZANAVIR SULFATE (HETERO LABS LTD III) APPROVAL= AP YEAR= 2022 |
Other links: |